• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动脉粥样硬化性心血管疾病模型中心肌和血管磷酸二酯酶 9A 的上调。

Upregulation of Myocardial and Vascular Phosphodiesterase 9A in A Model of Atherosclerotic Cardiovascular Disease.

机构信息

Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.

Institute of Internal Medicine, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.

出版信息

Int J Mol Sci. 2018 Sep 22;19(10):2882. doi: 10.3390/ijms19102882.

DOI:10.3390/ijms19102882
PMID:30249014
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6213954/
Abstract

Atherosclerosis is strongly associated with cardiac dysfunction and heart failure. Besides microvascular dysfunction and diminishment of the cardiac nitric oxide-Protein Kinase G (NO-PKG) pathway, recent evidence suggests that phosphodiesterase 9A (PDE9A) enzyme has an unfavorable role in pathological changes. Here, we characterized a rabbit model that shows cardiac dysfunction as a result of an atherogenic diet, and examined the myocardial PDE9A signaling. Rabbits were divided into Control (normal diet) and HC (atherogenic diet) groups. Cardiac function was evaluated by echocardiography. Vascular function was assessed, along with serum biomarkers. Histological stains were conducted, expression of selected proteins and cyclic guanosine monophosphate (cGMP) levels were determined. Signs of diastolic dysfunction were shown in HC animals, along with concentric hypertrophy and interstitial fibrosis. Endothelial function was diminished in HC rabbits, along with marked reduction in the aortic lumen, and increased left ventricle outflow tract (LVOT) pressures. A significant increase was shown in myocardial PDE9A levels in HC animals with unchanged vasodilator-stimulated phosphoprotein (VASP) phosphorylation and cGMP levels. Upregulation of PDE9A may be associated with early stage of cardiac dysfunction in atherosclerotic conditions. Since PDE9A is involved in cGMP degradation and in deactivation of the cardioprotective PKG signaling pathway, it may become an encouraging target for future investigations in atherosclerotic diseases.

摘要

动脉粥样硬化与心脏功能障碍和心力衰竭密切相关。除了微血管功能障碍和心脏一氧化氮蛋白激酶 G(NO-PKG)途径减少外,最近的证据表明,磷酸二酯酶 9A(PDE9A)酶在病理变化中具有不利作用。在这里,我们描述了一种兔模型,该模型由于动脉粥样硬化饮食而导致心脏功能障碍,并检查了心肌 PDE9A 信号。将兔子分为对照组(正常饮食)和 HC 组(动脉粥样硬化饮食)。通过超声心动图评估心功能。评估血管功能和血清生物标志物。进行组织学染色,测定选定蛋白质的表达和环鸟苷酸(cGMP)水平。HC 动物表现出舒张功能障碍的迹象,伴有同心性肥大和间质纤维化。HC 兔的内皮功能减弱,主动脉腔明显缩小,左心室流出道(LVOT)压力增加。HC 动物的心肌 PDE9A 水平显著升高,而血管扩张刺激磷酸蛋白(VASP)磷酸化和 cGMP 水平不变。PDE9A 的上调可能与动脉粥样硬化条件下心脏功能障碍的早期阶段有关。由于 PDE9A 参与 cGMP 降解和心脏保护性 PKG 信号通路的失活,因此它可能成为动脉粥样硬化疾病未来研究的一个有希望的靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48be/6213954/726f54cee2fc/ijms-19-02882-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48be/6213954/b190bd1d4911/ijms-19-02882-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48be/6213954/1e7e3542636b/ijms-19-02882-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48be/6213954/6f88c72865f8/ijms-19-02882-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48be/6213954/726f54cee2fc/ijms-19-02882-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48be/6213954/b190bd1d4911/ijms-19-02882-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48be/6213954/1e7e3542636b/ijms-19-02882-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48be/6213954/6f88c72865f8/ijms-19-02882-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48be/6213954/726f54cee2fc/ijms-19-02882-g004.jpg

相似文献

1
Upregulation of Myocardial and Vascular Phosphodiesterase 9A in A Model of Atherosclerotic Cardiovascular Disease.动脉粥样硬化性心血管疾病模型中心肌和血管磷酸二酯酶 9A 的上调。
Int J Mol Sci. 2018 Sep 22;19(10):2882. doi: 10.3390/ijms19102882.
2
Phosphodiesterase 9a Inhibition in Mouse Models of Diastolic Dysfunction.磷酸二酯酶 9a 抑制在舒张功能障碍小鼠模型中的作用。
Circ Heart Fail. 2020 May;13(5):e006609. doi: 10.1161/CIRCHEARTFAILURE.119.006609. Epub 2020 May 18.
3
Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease.磷酸二酯酶9A调控不依赖一氧化氮的环磷酸鸟苷及肥厚性心脏病。
Nature. 2015 Mar 26;519(7544):472-6. doi: 10.1038/nature14332. Epub 2015 Mar 18.
4
C33(S), a novel PDE9A inhibitor, protects against rat cardiac hypertrophy through upregulating cGMP signaling.C33(S),一种新型 PDE9A 抑制剂,通过上调 cGMP 信号通路来保护大鼠心肌肥厚。
Acta Pharmacol Sin. 2017 Sep;38(9):1257-1268. doi: 10.1038/aps.2017.38. Epub 2017 Jun 26.
5
PDE9A deficiency does not prevent chronic-hypoxic pulmonary hypertension in mice.PDE9A 缺乏并不预防慢性低氧性肺动脉高压小鼠模型的形成。
Physiol Rep. 2021 Sep;9(18):e15057. doi: 10.14814/phy2.15057.
6
Phosphodiesterase 9A inhibition improves aging-related increase in pulmonary vascular resistance in mice.磷酸二酯酶 9A 抑制可改善小鼠与衰老相关的肺血管阻力增加。
Geroscience. 2024 Oct;46(5):5191-5202. doi: 10.1007/s11357-024-01270-5. Epub 2024 Jul 9.
7
Phosphodiesterase 9A regulates central cGMP and modulates responses to cholinergic and monoaminergic perturbation in vivo.磷酸二酯酶 9A 调节中枢环鸟苷酸并调节体内胆碱能和单胺能扰动的反应。
J Pharmacol Exp Ther. 2012 May;341(2):396-409. doi: 10.1124/jpet.111.191353. Epub 2012 Feb 10.
8
High expression of the cGMP-specific phosphodiesterase, PDE9A, in sickle cell disease (SCD) and the effects of its inhibition in erythroid cells and SCD neutrophils.环磷酸鸟苷特异性磷酸二酯酶PDE9A在镰状细胞病(SCD)中的高表达及其抑制对红系细胞和SCD中性粒细胞的影响。
Br J Haematol. 2008 Sep;142(5):836-44. doi: 10.1111/j.1365-2141.2008.07264.x. Epub 2008 Jun 17.
9
The role of phosphodiesterase 9A inhibitors in heart failure.磷酸二酯酶 9A 抑制剂在心力衰竭中的作用。
Expert Opin Investig Drugs. 2024 Jun;33(6):543-547. doi: 10.1080/13543784.2024.2349813. Epub 2024 May 8.
10
Phosphodiesterase 9: insights from protein structure and role in therapeutics.磷酸二酯酶 9:从蛋白质结构角度的认识及其在治疗中的作用。
Life Sci. 2014 Jun 13;106(1-2):1-11. doi: 10.1016/j.lfs.2014.04.007. Epub 2014 Apr 16.

引用本文的文献

1
Atheroprotective role of vinpocetine: an old drug with new indication.长春西汀的抗动脉粥样硬化作用:一种具有新适应证的老药。
Inflammopharmacology. 2024 Dec;32(6):3669-3678. doi: 10.1007/s10787-024-01529-5. Epub 2024 Aug 14.
2
The anti-inflammatory properties of vinpocetine mediates its therapeutic potential in management of atherosclerosis.长春西汀的抗炎特性介导了其在动脉粥样硬化管理中的治疗潜力。
J Inflamm (Lond). 2024 Jun 10;21(1):19. doi: 10.1186/s12950-024-00394-x.
3
Therapeutic Aspects of Extract in a Rabbit Model of Atherosclerosis-Associated Diastolic Dysfunction.

本文引用的文献

1
Fenugreek (Trigonella Foenum-Graecum) Seed Flour and Diosgenin Preserve Endothelium-Dependent Arterial Relaxation in a Rat Model of Early-Stage Metabolic Syndrome.胡芦巴(Trigonella Foenum-Graecum)籽粉和薯蓣皂苷元可维持代谢综合征早期大鼠模型内皮依赖性动脉舒张功能。
Int J Mol Sci. 2018 Mar 10;19(3):798. doi: 10.3390/ijms19030798.
2
Murine Models of Heart Failure with Preserved Ejection Fraction: a "Fishing Expedition".射血分数保留的心力衰竭小鼠模型:一次“探索性研究”。
JACC Basic Transl Sci. 2017 Dec;2(6):770-789. doi: 10.1016/j.jacbts.2017.07.013. Epub 2017 Dec 25.
3
Targeting Obesity and Diabetes to Treat Heart Failure with Preserved Ejection Fraction.
Extract 治疗动脉粥样硬化相关性舒张功能障碍兔模型的疗效观察。
Int J Mol Sci. 2023 Aug 26;24(17):13253. doi: 10.3390/ijms241713253.
4
BAY-7081: A Potent, Selective, and Orally Bioavailable Cyanopyridone-Based PDE9A Inhibitor.BAY-7081:一种强效、选择性、口服生物可利用的基于氰基吡啶酮的 PDE9A 抑制剂。
J Med Chem. 2022 Dec 22;65(24):16420-16431. doi: 10.1021/acs.jmedchem.2c01267. Epub 2022 Dec 7.
5
Biological Assessment of the NO-Dependent Endothelial Function.NO 依赖型内皮功能的生物学评估。
Molecules. 2022 Nov 16;27(22):7921. doi: 10.3390/molecules27227921.
6
Changes of Hematological and Hemorheological Parameters in Rabbits with Hypercholesterolemia.高胆固醇血症家兔血液学和血液流变学参数的变化
Metabolites. 2021 Apr 17;11(4):249. doi: 10.3390/metabo11040249.
7
Evaluation of phosphodiesterase 9A as a novel biomarker in heart failure with preserved ejection fraction.评估磷酸二酯酶9A作为射血分数保留的心力衰竭的新型生物标志物。
ESC Heart Fail. 2021 Jun;8(3):1861-1872. doi: 10.1002/ehf2.13327. Epub 2021 Mar 30.
8
Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence.糖尿病心肌病的发病机制及潜在治疗策略:临床前与临床证据。
Nat Rev Cardiol. 2020 Sep;17(9):585-607. doi: 10.1038/s41569-020-0339-2. Epub 2020 Feb 20.
9
The Drug Candidate BGP-15 Delays the Onset of Diastolic Dysfunction in the Goto-Kakizaki Rat Model of Diabetic Cardiomyopathy.候选药物 BGP-15 可延缓糖尿病心肌病 Goto-Kakizaki 大鼠模型舒张功能障碍的发生。
Molecules. 2019 Feb 7;24(3):586. doi: 10.3390/molecules24030586.
针对肥胖和糖尿病治疗射血分数保留的心力衰竭
Front Endocrinol (Lausanne). 2017 Jul 17;8:160. doi: 10.3389/fendo.2017.00160. eCollection 2017.
4
A Novel Therapeutic Approach in the Treatment of Pulmonary Arterial Hypertension: Allium ursinum Liophylisate Alleviates Symptoms Comparably to Sildenafil.一种治疗肺动脉高压的新型治疗方法:熊葱叶提取物缓解症状的效果与西地那非相当。
Int J Mol Sci. 2017 Jul 4;18(7):1436. doi: 10.3390/ijms18071436.
5
Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction: Rationale and Design of the PARAGON-HF Trial.血管紧张素受体脑啡肽酶抑制剂治疗射血分数保留心力衰竭:PARAGON-HF 试验的原理和设计。
JACC Heart Fail. 2017 Jul;5(7):471-482. doi: 10.1016/j.jchf.2017.04.013. Epub 2017 Jun 26.
6
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel.低密度脂蛋白导致动脉粥样硬化性心血管疾病。1. 来自遗传、流行病学和临床研究的证据。欧洲动脉粥样硬化学会共识小组的共识声明。
Eur Heart J. 2017 Aug 21;38(32):2459-2472. doi: 10.1093/eurheartj/ehx144.
7
Anti-Atherogenic Properties of Allium ursinum Liophylisate: Impact on Lipoprotein Homeostasis and Cardiac Biomarkers in Hypercholesterolemic Rabbits.熊葱叶提取物的抗动脉粥样硬化特性:对高胆固醇血症兔脂蛋白稳态和心脏生物标志物的影响
Int J Mol Sci. 2016 Aug 10;17(8):1284. doi: 10.3390/ijms17081284.
8
Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap.射血分数保留的心力衰竭的表型特异性治疗:多器官路线图
Circulation. 2016 Jul 5;134(1):73-90. doi: 10.1161/CIRCULATIONAHA.116.021884.
9
Old dog, new tricks: novel cardiac targets and stress regulation by protein kinase G.老狗学新招:蛋白激酶G的新型心脏靶点与应激调节
Cardiovasc Res. 2016 Jul 15;111(2):154-62. doi: 10.1093/cvr/cvw107. Epub 2016 Jun 13.
10
Association between abdominal aortic plaque and coronary artery disease.腹主动脉斑块与冠状动脉疾病之间的关联。
Clin Interv Aging. 2016 May 19;11:683-8. doi: 10.2147/CIA.S104425. eCollection 2016.